#eoflow

[innonurse]

ChatGPT vs Elicit: GenAI battle in medical research

- By InnoNurse Staff -

A research team led by Professor Masaru Enomoto of Osaka Metropolitan University's Graduate School of Medicine gave identical clinical questions and literature selection criteria to two generative AIs, ChatGPT and Elicit.

Read more at Osaka Metropolitan University/EurekaALert!

///

Other recent news and insights

Soundwaves harden 3D-printed deep tissue treatments (Duke University)

Medtronic cancels its $738 million purchase of an insulin patch pump manufacturer EOFlow (Fierce Biotech)

Artificial intelligence in cancer drug development for the elderly (Impact Journals LLC/Medical Xpress)

In breast cancer screenings, AI can identify women at high risk (Karolinska Institutet/Medical Xpress)

UK: App for AI medical coaching Holly Health has raised £650,000 (UKTN)

[msinsights]

Artificial Pancreas Market Size, Share, Growth Insights, Top Vendors, Regions and Forecast by 2031

The Artificial Pancreas Market is characterized by a diverse range of stakeholders, including medical device manufacturers, healthcare providers, regulatory agencies, and patient advocacy groups. Collaboration among these stakeholders is essential to overcoming regulatory hurdles, ensuring patient safety, and promoting widespread adoption of artificial pancreas technology. Additionally, ongoing clinical research and trials play a crucial role in validating the safety and efficacy of artificial pancreas systems, further driving market expansion and acceptance. 

Get Free Sample PDF @ https://www.metastatinsight.com/request-sample/2759

Top Companies

Medtronic, Bigfoot Biomedical, Dexcom Inc, Tandem Diabetes Care Inc, Roche, Diabeloop SA, EoFlow, Beta Bionics Inc, Glooko Inc, Insulet Corporation.

The artificial pancreas is designed to mimic the function of the human pancreas, which regulates blood sugar levels by producing and releasing insulin. This groundbreaking technology integrates continuous glucose monitoring (CGM) with automated insulin delivery, effectively creating a closed-loop system that adjusts insulin dosage in real-time based on the individual's glucose levels. By automating this process, the artificial pancreas offers a more precise and personalized approach to diabetes management, reducing the burden of constant glucose monitoring and manual insulin administration. 

One of the key drivers fueling the growth of the Global Artificial Pancreas market is the increasing prevalence of diabetes worldwide. With diabetes emerging as a global health epidemic, there is a growing demand for innovative solutions that can help individuals better manage their condition and improve long-term outcomes. The artificial pancreas represents a significant advancement in diabetes care, offering the potential to enhance glycemic control, reduce the risk of hypoglycemia, and ultimately improve overall quality of life for patients. 

Browse Complete Report @ https://www.metastatinsight.com/report/artificial-pancreas-market

Furthermore, advancements in sensor technology, insulin pumps, and algorithm development have paved the way for the commercialization of artificial pancreas systems. These technological innovations have enabled the creation of more sophisticated and reliable devices capable of delivering precise insulin dosages based on real-time glucose data. As a result, artificial pancreas systems have become increasingly accessible to individuals with diabetes, driving market growth and adoption worldwide. 

[healthcaremarketanalysis]

Digital Health Market worth $549.7 billion by 2028

The global digital health market, valued at $180.2 billion in 2023, is projected to reach $549.7 billion by 2028, growing at a CAGR of 25.0%. Key factors driving market growth include the increasing penetration of smartphones and mobile platforms, supportive initiatives, strategic alliances, a rising geriatric population, and a focus on patient-centric healthcare solutions. However, high deployment costs and interoperability issues pose challenges. The telehealthcare segment accounted for the largest market share in 2022, driven by demand during the COVID-19 pandemic and improved attitudes towards virtual care. North America holds the largest market share and is expected to grow the fastest due to technological advancements and a favorable regulatory environment. Prominent players in the market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Abbott, and Apple, Inc. Recent developments include Medtronic’s acquisition of EOFlow and GE HealthCare’s partnership with Advantus Health Partners.

Download an Illustrative overview:

"Hardware segment is expected to grow at the highest rate during the forecast period"

Based on offering, the digital health market is segmented into hardware, software, services and applications. In 2022, the hardware segment is expected to grow at the highest CAGR during the forecast period. The highest growth rate is attributed to increased patient demand for convenient healthcare solutions, healthcare provider adoption for improved care and operations, and expansion of telehealth & chronic disease management.

"Telehealthcare technology segment accounted for the largest share of the global digital health market"

Based on technology, the digital health market is segmented into telehealthcare, mHealth, health management solutions and digital therapeutics. The telehealthcare segment accounted for the largest share of the global market in 2022. Factors such as increased demand for remote healthcare services, especially due to the COVID-19 pandemic, accelerated telehealthcare adoption.

"The chronic disease management application segment accounted for the largest share of the digital health industry in 2022"

On the basis of application, the digital health market is segmented into chronic disease management, behavioral health, health & fitness and others. The chronic disease management segment accounted for the largest share of the market in 2022 period, owing to the increasing prevalence of chronic conditions, an aging population, and lifestyle-related health issues.

"Patients & Consumers segment is expected to grow at highest groeth rate in the global digital health market"

On the basis of end user, the digital health market is segmented into providers, payers and patients & consumers. The high growth of this segment is attributed to increasing awareness of self-health management, proliferation of smartphones and wearable devices that has made health tracking and monitoring more accessible and convenient.

North America accounted for the largest share of the global Digital Health Industry in 2022.

The Digital Health market is segmented into four key regions—North America, Europe, APAC, and the Rest of the World (RoW). North America, being the early adopter of advanced technologies, has captured the largest share of the Digital Health market in 2022, followed by Europe and APAC. It is also projected to register the highest CAGR. North America is the fastest-growing regional segment for digital health due to its technological development, expansion in the healthcare industry, favorable regulatory environment, and the presence of key players and innovation hubs.

Request Sample Pages:

Digital Health Market Dynamics:

Drivers

Increasing penetration of smartphones, tablets, and other mobile platforms

Supportive initiatives and increasing strategic alliances

Rising geriatric population and subsequent increase in prevalence of chronic diseases

Rising focus on patient-centric healthcare solutions

 Restraints

High cost of deployment of digital health solutions for small and medium-sized hospitals in emerging countries

Interoperability issues

 Opportunities

Shift toward intelligent health ecosystem to deliver personalized health experiences

Digital health solutions for universal healthcare access

Improving regulatory support and reimbursements

Advancements in digital health

 Challenges

Healthcare gap in emerging economies

Privacy and security concerns

Key Market Players of Digital Health Industry:

Prominent players in the digital health market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), OMRON Corporation (Japan), Fitbit, Inc. (A google company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT & T, Inc. (US), Veradigm LLC (US), Noom, Inc. (US), Teladoc Health, Inc. (US), Omada Health Inc. (US), Dexcom, Inc. (US), Biotricity (US), iHealth Labs Inc (US), my mhealth Limited (UK), athenahealth (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US) and Qardio, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product upgrades, collaborations, agreements, partnerships, and acquisitions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Recent Developments:

In May 2023 Medtronic (Ireland) acquired EOFlow Co. Ltd. (South Korea) to expand its ability to treat patients with diabetes.

In March 2023, GE HealthCare (US) partnered with Advantus Health Partners (US) to sign a multi-year contract to expand access to Healthcare Technology Management Services.

In April 2023, Abbott (US) acquired Cardiovascular Systems, Inc. (CSI) (US) to gain a complementary treatment option for vascular illness. The highly advanced atherectomy technology from CSI prepares vessels for angioplasty or stenting to restore blood flow.

Related Links:

[tritonmarketresearch]

Growing Diabetes Incidence to Fuel the Global Insulin Patch Pump Market

Triton Market Research presents the ‘Global Insulin Patch Pump Market’ report sectioned by Delivery Mode (Bolus, Basal, Basal & Bolus), By Product Type (Reusable, Disposable), By Disease Indication (Type 1 Diabetes, Type 2 Diabetes), by Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies) and by Regional Outlook (Middle East and Africa, North America, Europe, Asia-Pacific, Latin America).

The report further discusses the Market Summary, Industry Outlook (Parent Market Analysis, Impact Analysis, Market Maturity Analysis, Porter’s Five Forces Analysis, Industry Components, Regulatory Framework, Key Market Strategies, Key Buying Impact Analysis, Drivers, Challenges, Opportunities, Analyst Perspective), Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2023-2030).

As per the report by Triton Market Research, the global insulin patch pump market is anticipated to develop at a CAGR of 10.54% in the forecast years from 2023 to 2030.

Request Free Sample Report:

https://www.tritonmarketresearch.com/reports/insulin-patch-pump-market#request-free-sample

 Insulin patch pumps have become a practical option for patients who need insulin therapy as the medical field develops. These devices are more user-friendly, affordable, and smaller than conventional insulin pumps, which makes them a preferred option for patients.

Additionally, technological developments have lessened the need for regular monitoring, which has increased patient demand for a more practical alternative. As a result, more patients are choosing insulin patch pumps over conventional insulin pumps as the knowledge of the advantages of these devices grows. The rising awareness regarding such advanced solutions is expected to drive the global insulin patch pump market’s growth over the forecast period.

While insulin pumps have advantages like accurate dosing and ease, they also come with risks like low blood sugar, weight gain, hemorrhage, and scarring. For instance, the use of interoperable t:Slim X2 pumps is associated with risks such as infection, bleeding, discomforts, or skin irritations like redness, swelling, bruising, itching, scarring, and skin discoloration. The possibility of such dangers may have an impact on the growth of the global insulin patch pump market over the forecasted period.

North America leads the global market, accounting for the highest revenue share in 2022. The market for insulin patch pumps in the region is expected to expand significantly, mostly as a result of rising diabetes incidence, rising per capita income, and rising healthcare costs.

As diabetes affects 11.3% of the population in the US, the market for insulin patch pumps is anticipated to rise at a faster rate there. Additionally, during the projected period, the market expansion is anticipated to be fueled by the use of smart devices and advanced technologies like artificial intelligence & data analytics, as well as the presence of established market competitors.

Debiotech SA, EOFlow Co Ltd, Tandem Diabetes Care Inc, CeQur SA, Terumo Corporation, Medtronic Plc, F Hoffmann La Roche AG, Medtrum Technologies Inc, and Insulet Corporation are some of the leading players operating in this market.

Players in the market require high seed capital. Moreover, the stringent government regulations and the strong presence of established players make it difficult for new entrants to penetrate the market and disrupt the portfolio of leading & gain a significant market share. Moreover, established players make significant investments in research & development to innovate their products and maintain their market dominance. Therefore, the competitive rivalry in the market is high.

 Contact Us:

sales@tritonmarketresearch.com

Phone: +44 7441 911839

[desaletushki]

High Worldwide Demand of Insulin Patch Pumps in Covid19 Pandemic

The global insulin patch pumps market size is expected to reach USD 1.7 Billion by 2027, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.9% over the forecast period. The market is primarily driven by factors such as increasing diabetic population and rising awareness about advanced diabetes management solutions. Moreover, technological advancements and several product launches in the field of insulin patch pumps are further augmenting growth. 

Patch pumps are easy to use and more convenient than conventional insulin pumps. In addition, they are more affordable than conventional insulin pumps and are rapidly capturing a significant share of the insulin patch pumps market. Key players are using novel technologies and offer user-friendly insulin delivery solutions at lower prices. This is expected to increase the frequency of product launches during the forecast period, boosting overall growth.

Increasing healthcare expenditure related to diabetes and rising number of FDA approvals are further aiding growth. For instance, in March 2019, a South Korean Company-EoFlow-received FDA approval for its newly designed patch pump-EoPatch in the U.S.

Browse Full Report with TOC and Free Sample Copy@ https://www.grandviewresearch.com/industry-analysis/insulin-patch-pump-market

Regional Insights

Regionally, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the market owing to availability of major brands of insulin patch pumps. Moreover, increasing healthcare expenditure and rising frequency of FDA approvals is also aiding growth in the region. For instance, in 2019, South Korean Company EoFlow received FDA approval for its newly designed patch pump-EOPatch-in the U.S.

Asia Pacific is expected to grow at the fastest pace due to factors such as rapidly growing diabetic population and increasing awareness about advanced digital diabetes management solutions in the region. In addition, increasing product launches and technological advancements in the field of insulin patch pumps are expected to aid regional growth.

 Key Companies & Market Share Insights

 Some of the leading players are Roche Diagnostics; Medtronic Plc; Valeritus; Insulet Corporation; Cellnovo Ltd; and CeQur. The major players are focusing on mergers & acquisitions, technological collaborations, and innovative product launches. For instance, in July 2018, Cequr purchased a certain asset from Calibra Medical-a subsidiary of Johnson & Johnson. These assets include latter’s wearable insulin delivery technology.

 Contact Us:

Grand View Research, Inc. 201 Spear Street 1100, San Francisco, CA 94105 United States

Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com

[moidiabet]

Система ввода инсулина с обратной связью EOFlow получила статус «прорывного устройства»

[ajjpatil]

Insulin Patch Pump Market 2019- Global Industry Details by Overview, Size, Top Manufacturers, Trends, Demand, Overview, Forecast to 2025

Industry Outlook and Trend Analysis

Insulin patch pump market is expected to experience significant growth in coming years between 2017 and 2025. The market is primarily driven by rising incidence of diabetes worldwide. Diabetes is on the rise globally with a steady increase around the world especially in the world’s middle-income countries. According to World Health Organization’s Global Report on Diabetes published in 2016, the global prevalence of diabetes has nearly doubled between 1980 and 2014, rising from 4.7% to 8.5% of the adult population. In terms of number of patients, the prevalence increased from 108 million in 1980 to 422 million cases in 2014. With increasing awareness among diabetics about technologically advanced devices for treating diabetes, the market for insulin patch pumps is expected to witness favorable growth during the forecast period. However, the complexity of such devices can sometimes prevent people from readily adopting them thus restraining the market growth.

Get Free Sample Report: https://www.crystalmarketresearch.com/report-sample/HC07183

Insulin Type Outlook and Trend Analysis

Basal insulin is an insulin type which helps to stabilize blood sugar levels during periods of fasting such as during sleep or between meals. During such period, the body releases sugar (glucose) into the bloodstream which energizes the body’s cells. Basal insulin keeps a check on the levels of such glucose. Bolus insulin refers to the short acting insulin in order to balance the carbohydrate intake with meals. Basal-bolus therapy usually involves ordering multiple daily intake of insulin to replicate the natural production of insulin in the human body.

Regional Outlook and Trend Analysis

North America held a significant share of the insulin patch pump market in 2016 due to the availability of FDA approved insulin patch pumps such as the OmniPod Insulin Management System manufactured by Insulet Corporation and V-GO disposable insulin delivery device manufactured by Valeritas, Inc. The Asia-Pacific market has not experienced any substantial growth due to lack of large scale adoption of advanced therapies for diabetes management but can experience favorable growth in coming years owing to increasing awareness related to diabetes management in the region.

Competitive Outlook and Trend Analysis

The key players operating in the global insulin patch pump market emphasize on product development in order to introduce improved diabetes management systems and capture a larger share of the market. Some of the major players in this market are, Insulet Corporation, Valeritas Holdings, Inc., CeQur SA, Cellnovo Limited, Debiotech S.A.,  EOFLOW CO.,LTD., Unilife Corporation and Becton, Dickinson and Company.

Get Discount For This Report: https://www.crystalmarketresearch.com/check-discount/HC07183

Ethyl Lactate Market Segmentation:

By Type of Insulin:

Basal Insulin

Bolus Insulin

Basal-Bolus Insulin

By End User:

Hospitals

Private     clinics

Online pharmacies

Retail pharmacies

By Region:

·         North America

o   U.S

o   Canada

o   Mexico

·         Europe

o   Germany

o   France

o   UK

o   Italy

o   Spain

o   Rest of Europe

·         Asia-Pacific

o   Japan

o   China

o   Australia

o   India

o   South Korea

o   Rest of Asia Pacific

·         Rest of the World

o   Brazil

o   South Africa

o   Saudi Arabia

o   United Arab Emirates

o   Others

Enquiry Before Buying This Report: https://www.crystalmarketresearch.com/send-an-enquiry/CM09222

About Crystal Market Research: Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us: Judy S 304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States Toll Free: +1-888-213-4282 Email: sales@crystalmarketresearch.com

[randybenedict]

EOFlow wins breakthrough status for wearable closed-loop insulin delivery tech

Korean medtech company EOFlow said last week that it won breakthrough status from the FDA for its closed-loop automated insulin delivery system for people with Type 1 diabetes.

The EOPancreas system features a wearable patch, continuous glucose monitoring systems and a closed-loop blood glucose control algorithm.

Get the full story at our sister site, Drug Delivery Business News.

The post EOFlow wins breakthrough status for wearable closed-loop insulin delivery tech appeared first on MassDevice.

from MassDevice https://ift.tt/2TNNNDd

[healthcaremarketanalysis]

Digital Health Market Size, Share, Trends and Revenue Forecast [2028]

 Digital Health Market in terms of revenue was estimated to be worth $180.2 billion in 2023 and is poised to reach $549.7 billion by 2028, growing at a CAGR of 25.0% from 2023 to 2028 according to a new report by MarketsandMarkets. The growth of this market is driven by the expansion of telemedicine and telehealth services, enhanced patient engagement and empowerment and increased investment in health tech startups. On the other hand, variability in healthcare infrastructure and digital literacy, reimbursement and payment issues are some of the factors challenging the growth of the market.

Download an Illustrative overview:

Browse in-depth TOC on "Digital Health Market"

231 - Tables

49 - Figures

301 – Pages

North America accounted for the largest share of the global Digital Health Industry in 2022.

The Digital Health market is segmented into four key regions—North America, Europe, APAC, and the Rest of the World (RoW). North America, being the early adopter of advanced technologies, has captured the largest share of the Digital Health market in 2022, followed by Europe and APAC. It is also projected to register the highest CAGR. North America is the fastest-growing regional segment for digital health due to its technological development, expansion in the healthcare industry, favorable regulatory environment, and the presence of key players and innovation hubs.

Request Sample Pages:

Digital Health Market Dynamics:

Drivers

·         Increasing penetration of smartphones, tablets, and other mobile platforms

·         Supportive initiatives and increasing strategic alliances

·         Rising geriatric population and subsequent increase in prevalence of chronic diseases

·         Rising focus on patient-centric healthcare solutions

 Restraints

·         High cost of deployment of digital health solutions for small and medium-sized hospitals in emerging countries

·         Interoperability issues

 Opportunities

·         Shift toward intelligent health ecosystem to deliver personalized health experiences

·         Digital health solutions for universal healthcare access

·         Improving regulatory support and reimbursements

·         Advancements in digital health

 Challenges

·         Healthcare gap in emerging economies

·         Privacy and security concerns

Key Market Players of Digital Health Industry:

Prominent players in the digital health market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), OMRON Corporation (Japan), Fitbit, Inc. (A google company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT & T, Inc. (US), Veradigm LLC (US), Noom, Inc. (US), Teladoc Health, Inc. (US), Omada Health Inc. (US), Dexcom, Inc. (US), Biotricity (US), iHealth Labs Inc (US), my mhealth Limited (UK), athenahealth (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US) and Qardio, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product upgrades, collaborations, agreements, partnerships, and acquisitions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

· By Supply Side: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)

· By Demand Side: Purchase Managers (45%), Head Of AI, ML, Drud Discovery & Computational Molecular Design (30%), Research Scientists (25%)

· By Designation: C-level (31%), Director-level (25%), and Others (44%)

· By Region: North America (45%), Europe (20%), Asia Pacific (28%), and RoW (7%)

Inquiry Before Buying:

 Recent Developments:

· In May 2023 Medtronic (Ireland) acquired EOFlow Co. Ltd. (South Korea) to expand its ability to treat patients with diabetes.

· In March 2023, GE HealthCare (US) partnered with Advantus Health Partners (US) to sign a multi-year contract to expand access to Healthcare Technology Management Services.

· In April 2023, Abbott (US) acquired Cardiovascular Systems, Inc. (CSI) (US) to gain a complementary treatment option for vascular illness. The highly advanced atherectomy technology from CSI prepares vessels for angioplasty or stenting to restore blood flow.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

[sammfeaster]

JDRF backs EOPatch, a tiny, wearable insulin pump

The Juvenile Diabetes Research Foundation (JDRF) has partnered with South Korean medical device company EOFlow to accelerate the development of EOPatch, the company's wearable insulin pump. from MobiHealthNews http://www.mobihealthnews.com/content/jdrf-backs-eopatch-tiny-wearable-insulin-pump via IFTTT

[healthcaremarketanalysis]

Digital Health Market Size, Share, Trends and Revenue Forecast [2028]

Digital Health Market in terms of revenue was estimated to be worth $180.2 billion in 2023 and is poised to reach $549.7 billion by 2028, growing at a CAGR of 25.0% from 2023 to 2028 according to a new report by MarketsandMarkets. The growth of this market is driven by the expansion of telemedicine and telehealth services, enhanced patient engagement and empowerment and increased investment in health tech startups. On the other hand, variability in healthcare infrastructure and digital literacy, reimbursement and payment issues are some of the factors challenging the growth of the market.

Download an Illustrative overview:

Browse in-depth TOC on "Digital Health Market"

231 - Tables

49 - Figures

301 – Pages

North America accounted for the largest share of the global Digital Health Industry in 2022.

The Digital Health market is segmented into four key regions—North America, Europe, APAC, and the Rest of the World (RoW). North America, being the early adopter of advanced technologies, has captured the largest share of the Digital Health market in 2022, followed by Europe and APAC. It is also projected to register the highest CAGR. North America is the fastest-growing regional segment for digital health due to its technological development, expansion in the healthcare industry, favorable regulatory environment, and the presence of key players and innovation hubs.

Request Sample Pages:

Digital Health Market Dynamics:

Drivers

Increasing penetration of smartphones, tablets, and other mobile platforms

Supportive initiatives and increasing strategic alliances

Rising geriatric population and subsequent increase in prevalence of chronic diseases

Rising focus on patient-centric healthcare solutions

 Restraints

High cost of deployment of digital health solutions for small and medium-sized hospitals in emerging countries

Interoperability issues

 Opportunities

Shift toward intelligent health ecosystem to deliver personalized health experiences

Digital health solutions for universal healthcare access

Improving regulatory support and reimbursements

Advancements in digital health

 Challenges

Healthcare gap in emerging economies

Privacy and security concerns

Key Market Players of Digital Health Industry:

Prominent players in the digital health market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), OMRON Corporation (Japan), Fitbit, Inc. (A google company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT & T, Inc. (US), Veradigm LLC (US), Noom, Inc. (US), Teladoc Health, Inc. (US), Omada Health Inc. (US), Dexcom, Inc. (US), Biotricity (US), iHealth Labs Inc (US), my mhealth Limited (UK), athenahealth (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US) and Qardio, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product upgrades, collaborations, agreements, partnerships, and acquisitions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

· By Supply Side: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)

· By Demand Side: Purchase Managers (45%), Head Of AI, ML, Drud Discovery & Computational Molecular Design (30%), Research Scientists (25%)

· By Designation: C-level (31%), Director-level (25%), and Others (44%)

· By Region: North America (45%), Europe (20%), Asia Pacific (28%), and RoW (7%)

Inquiry Before Buying:

 Recent Developments:

· In May 2023 Medtronic (Ireland) acquired EOFlow Co. Ltd. (South Korea) to expand its ability to treat patients with diabetes.

· In March 2023, GE HealthCare (US) partnered with Advantus Health Partners (US) to sign a multi-year contract to expand access to Healthcare Technology Management Services.

· In April 2023, Abbott (US) acquired Cardiovascular Systems, Inc. (CSI) (US) to gain a complementary treatment option for vascular illness. The highly advanced atherectomy technology from CSI prepares vessels for angioplasty or stenting to restore blood flow.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

[crystalmarketresearch]

Insulin Patch Pump Market Analysis- Size, Share, Growth, Industry Demand, and Forecast 2025

Insulin Patch Pump industry -Regional Outlook and Trend Analysis: North America held a significant share of the insulin patch pump market in 2016 due to the availability of FDA approved insulin patch pumps such as the OmniPod Insulin Management System manufactured by Insulet Corporation and V-GO disposable insulin delivery device manufactured by Valeritas, Inc. The Asia-Pacific market has not experienced any substantial growth due to lack of large scale adoption of advanced therapies for diabetes management but can experience favorable growth in coming years owing to increasing awareness related to diabetes management in the region. Browse Full market data Tables and in-depth TOC on Insulin Patch Pump Market at: www.crystalmarketresearch.com/report/insulin-patch-pump-m... . Insulin Patch Pump industry -Competitive Insights: The key players operating in the global insulin patch pump market emphasize on product development in order to introduce improved diabetes management systems and capture a larger share of the market. Some of the major players in this market are, Insulet Corporation, Valeritas Holdings, Inc., CeQur SA, Cellnovo Limited, Debiotech S.A., EOFLOW CO.,LTD., Unilife Corporation and Becton, Dickinson and Company. Insulin Patch Pump industry -Industry Outlook and Trend Analysis: Insulin Patch Pump Market is expected to experience significant growth in coming years between 2017 and 2025. The market is primarily driven by rising incidence of diabetes worldwide. Diabetes is on the rise globally with a steady increase around the world especially in the world’s middle-income countries. According to World Health Organization’s Global Report on Diabetes published in 2016, the global prevalence of diabetes has nearly doubled between 1980 and 2014, rising from 4.7% to 8.5% of the adult population. In terms of number of patients, the prevalence increased from 108 million in 1980 to 422 million cases in 2014. With increasing awareness among diabetics about technologically advanced devices for treating diabetes, the market for insulin patch pumps is expected to witness favorable growth during the forecast period. However, the complexity of such devices can sometimes prevent people from readily adopting them thus restraining the market growth. Request sample Copy of this Report: www.crystalmarketresearch.com/report-sample/HC07183 Insulin Type Outlook and Trend Analysis: Basal insulin is an insulin type which helps to stabilize blood sugar levels during periods of fasting such as during sleep or between meals. During such period, the body releases sugar (glucose) into the bloodstream which energizes the body’s cells. Basal insulin keeps a check on the levels of such glucose. Bolus insulin refers to the short acting insulin in order to balance the carbohydrate intake with meals. Basal-bolus therapy usually involves ordering multiple daily intake of insulin to replicate the natural production of insulin in the human body. The Insulin Patch Pump Market is segmented as follows- Insulin Patch Pump Market, By Type of Insulin, Estimates and Forecast, 2016-2025 ($Million) Basal Insulin Bolus Insulin Basal-bolus Insulin Insulin Patch Pump Market, By End User, Estimates and Forecast, 2016-2025 ($Million) Hospitals Retail Pharmacies Private Clinics Online Pharmacies Reasons to buy a Exclusive report ? 1) An extensive research study on the Global Insulin Patch Pump market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Insulin Patch Pump market. 2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise. 3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches. Click to Buy In-depth TOC "Exclusive report": www.crystalmarketresearch.com/checkout/HC07183 Major TOC of Insulin Patch Pump Market: Chapter1. Introduction Chapter2. Executive Summary Chapter3. Market Overview Chapter 4.Insulin Patch Pump Market, By Type of Insulin 4.1.Introduction 4.2.Insulin Patch Pump Market Assessment and Forecast, By Type of Insulin, 2016-2025 4.3.Basal Insulin 4.3.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million) 4.4.Bolus Insulin 4.4.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million) 4.5.Basal-bolus Insulin 4.5.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million) Chapter 5.Insulin Patch Pump Market, By End User 5.1.Introduction 5.2.Insulin Patch Pump Market Assessment and Forecast, By End User, 2016-2025 5.3.Hospitals 5.3.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million) 5.4.Private Clinics 5.4.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million) 5.5.Online Pharmacies 5.5.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million) 5.6.Retail Pharmacies 5.6.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million) Chapter6. Insulin Patch Pump Market, By Region Chapter7. Company Profiles Chapter8. Global Insulin Patch Pump Market Competition, by Manufacturer Chapter9. Insulin Patch Pump Market Forecast (2018-2025) …CONTINUED FOR TOC List of Figures Figure 1.Insulin Patch Pump Market Share, By Type of Insulin, 2016 & 2025 Figure 2.Insulin Patch Pump Market, By End User, 2016, ($Million) Figure 3.Insulin Patch Pump Market, By Region, 2016, ($Million) Figure 4.Insulet Corporation: Net Revenues, 2014-2016 ($Million) Figure 5.Insulet Corporation: Net Revenue Share, By Segment, 2016 Figure 6.Insulet Corporation: Net Revenue Share, By Geography, 2016 Figure 7.Valeritas Holdings, Inc.: Net Revenues, 2014-2016 ($Million) Figure 8.Valeritas Holdings, Inc.: Net Revenue Share, By Segment, 2016 Figure 9.Valeritas Holdings, Inc.: Net Revenue Share, By Geography, 2016 Figure 10.Cellnovo Limited: Net Revenues, 2014-2016 ($Million) Figure 11.Cellnovo Limited: Net Revenue Share, By Segment, 2016 Continue… List of Tables Table 1.Insulin Patch Pump Market, By Type of Insulin ($Million), 2016-2025 Table 2.Basal Insulin Market, By Region ($Million), 2016-2025 Table 3.Bolus Insulin Market, By Region ($Million), 2016-2025 Table 4.Basal-bolus Insulin Market, By Region ($Million), 2016-2025 Table 5.Insulin Patch Pump Market, By End User ($Million), 2016-2025 Table 6.Hospitals Market, By Region ($Million), 2016-2025 Table 7.Private Clinics Market, By Region ($Million), 2016-2025 Table 8.Online Pharmacies Market, By Region ($Million), 2016-2025 Table 9.Retail Pharmacies Market, By Region ($Million), 2016-2025 Table 11.Insulin Patch Pump Market, By Region ($Million), 2016-2025 Table12.North America Insulin Patch Pump Market, By Country, 2016-2025 ($Million) Continue… We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast. Feel free to get in touch for discounts and customized details: www.crystalmarketresearch.com/check-discount/HC07183 About Crystal Market Research: Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy. Contact: Crystal Market Research Judy 304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States